Dindin, Cerilo C.
HRN: 25-63-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/02/2026
01/09/2026
IV
2.25g
Q8
Cap
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes